🇺🇸 FDA
Patent

US 10933137

Pharmaceutical compositions comprising meloxicam

granted A61KA61K31/4439A61K31/5415

Quick answer

US patent 10933137 (Pharmaceutical compositions comprising meloxicam) held by AXSOME THERAPEUTICS, INC. expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/4439, A61K31/5415, A61K45/06, A61K47/02